Efficacy News and Research

RSS
Tolerx publishes follow-up data from study of otelixizumab therapy for new onset T1DM patients

Tolerx publishes follow-up data from study of otelixizumab therapy for new onset T1DM patients

Patient enrollment in Spinal Restoration' Phase III study of Biostat System now underway

Patient enrollment in Spinal Restoration' Phase III study of Biostat System now underway

Iverson Genetic Diagnostics to conduct WARFARIN clinical study

Iverson Genetic Diagnostics to conduct WARFARIN clinical study

Promedior raises $12M in Series C financing

Promedior raises $12M in Series C financing

MRSA Survivors Network urges CDC to declare MRSA an epidemic

MRSA Survivors Network urges CDC to declare MRSA an epidemic

PERSEUS clinical program demonstrates positive results of TAXUS Element Paclitaxel-Eluting Stent System

PERSEUS clinical program demonstrates positive results of TAXUS Element Paclitaxel-Eluting Stent System

Medtronic' Endeavor DES demonstrates safety and efficacy profile for coronary artery disease treatment

Medtronic' Endeavor DES demonstrates safety and efficacy profile for coronary artery disease treatment

Stage IV colorectal cancer: Therapy that improves overall survival over IFL/bevacizumab will earn 60% patient share

Stage IV colorectal cancer: Therapy that improves overall survival over IFL/bevacizumab will earn 60% patient share

Obesity limits body's ability to fight infections

Obesity limits body's ability to fight infections

PERSEUS clinical program comparing TAXUS Element Stent to prior-generation stents: 12-month results

PERSEUS clinical program comparing TAXUS Element Stent to prior-generation stents: 12-month results

Uterine fibroids: Promising new minimally invasive treatment using high-energy ultrasound waves

Uterine fibroids: Promising new minimally invasive treatment using high-energy ultrasound waves

Boston Scientific announces results from HORIZONS AMI trial assessing Express bare-metal stent

Boston Scientific announces results from HORIZONS AMI trial assessing Express bare-metal stent

CYPHER Sirolimus-eluting Coronary Stent provides better outcome compared to Medtronic’s Endeavor Stent

CYPHER Sirolimus-eluting Coronary Stent provides better outcome compared to Medtronic’s Endeavor Stent

Genzyme, Isis Pharmaceuticals: Phase 3 study of mipomersen in hoFH patients meets primary endpoint

Genzyme, Isis Pharmaceuticals: Phase 3 study of mipomersen in hoFH patients meets primary endpoint

Nuvo Research commences enrollment in WF10 Phase 2 clinical trial for allergic rhinitis

Nuvo Research commences enrollment in WF10 Phase 2 clinical trial for allergic rhinitis

TCAD therapy superior to double combinations and monotherapy against influenza viruses

TCAD therapy superior to double combinations and monotherapy against influenza viruses

CytRx plans five Phase 2 clinical trials with oncology drug candidates

CytRx plans five Phase 2 clinical trials with oncology drug candidates

Metastatic melanoma: Involvement of immune system in response to PV-10 therapy

Metastatic melanoma: Involvement of immune system in response to PV-10 therapy

YM BioSciences: Two posters on nimotuzumab accepted for presentation at AACR

YM BioSciences: Two posters on nimotuzumab accepted for presentation at AACR

Neurologix receives US PTO Notice of Allowance concerning treatment approach for epilepsy

Neurologix receives US PTO Notice of Allowance concerning treatment approach for epilepsy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.